中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa

文献类型:期刊论文

作者Zhang, Yu; Guo, Lingli; Yang, Guangmei; Guo, Feng; Di, Yingtong; Li, Shunlin; Chen, Duozhi; Hao, Xiaojiang
刊名FITOTERAPIA
出版日期2015
卷号100页码:150-155
关键词Tabernaemontana corymbosa Bisindole alkaloids Tabercorines A-C Cytotoxicity
英文摘要Ten vobasinyl-ibogan type bisindole alkaloids, including three new ones, tabercorines A-C (1-3), and a new natural product, 17-acetyl-tabemaecorymbosine A (4), were isolated from the twigs and leaves of Tabernaemontana coymbosa. Their structures were elucidated on the basis of spectroscopic data, and the NMR data of 17-acetyl-tabemaecorymbosine A (4) was assigned and reported for the first time. The absolute configurations of 1-4 were determined by CD exciton chirality method. All new compounds were evaluated for in vitro cytotoxicity against various human cancer cell lines. Compounds 1 and 4 showed significant inhibitory effects with IC50 values comparable to those of cisplatin. (C) 2014 Elsevier B.V. All rights reserved.
类目[WOS]Chemistry, Medicinal ; Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]INDOLE ALKALOIDS ; ERVATAMIA-CHINENSIS
收录类别SCI
语种英语
WOS记录号WOS:000349881300019
公开日期2015-07-07
源URL[http://ir.kib.ac.cn/handle/151853/20431]  
专题昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室
作者单位Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Yu,Guo, Lingli,Yang, Guangmei,et al. New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa[J]. FITOTERAPIA,2015,100:150-155.
APA Zhang, Yu.,Guo, Lingli.,Yang, Guangmei.,Guo, Feng.,Di, Yingtong.,...&Hao, Xiaojiang.(2015).New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa.FITOTERAPIA,100,150-155.
MLA Zhang, Yu,et al."New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa".FITOTERAPIA 100(2015):150-155.

入库方式: OAI收割

来源:昆明植物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。